Crossmark

Sparsentan versus Irbesartan bei fokal segmentaler Glomerulosklerose

Published Online: 2024-01-24

Published Print: 2024-02

Authors

Ueberdiek, Lars

Jehn, Ulrich
License Information

Text and Data Mining valid from 2024-01-24

Version of Record valid from 2024-01-24
More Information

Article History

Accepted: 17 January 2024

First Online: 24 January 2024

Interessenkonflikt

: L. Ueberdiek und U. Jehn geben an, dass kein Interessenkonflikt besteht.

Document is current